Patent war intensifies: Glenmark launches generic version of Merck’s Januvia
As reported by Rupali Mukherjee of Times of India, in a move which will transform the landscape of the Indian pharma industry, Glenmark has launched a cheaper generic version of pharma multinational Merck’s blockbuster anti-diabetes drug Januvia (Sitagliptin phosphate). The generic vs. innovator battle earlier restricted to anticancer and anti-retroviral meds has now entered uncharted territory; just when you thought things couldn’t get any murkier! Image from here Numbers and market dynamics: Owing to obesity and lifestyle changes, India has […]
Patent war intensifies: Glenmark launches generic version of Merck’s Januvia Read More »